New insights on the arylpiperazinylalkyl pyridazinone ET1 as potent antinociceptive and anti-inflammatory agent
- 1 December 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 888, 173572
Abstract
No abstract availableKeywords
Funding Information
- Istituto Superiore di Sanità
- Ministero dell’Istruzione, dell’Università e della Ricerca (2017A95NCJ_002)
This publication has 83 references indexed in Scilit:
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- 4-Amino-3(2H)-pyridazinones bearing arylpiperazinylalkyl groups and related compounds: synthesis and antinociceptive activityIl Farmaco, 2003
- Human μ opiate receptorFEBS Letters, 1994
- Further characterization of [3H]ifenprodil binding in rat brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Genomic Cloning, Heterologous Expression and Pharmacological Characterization of a Human Histamine H1 ReceptorBiochemical and Biophysical Research Communications, 1993
- Cloning and functional characterization of a human Al adenosine receptorBiochemical and Biophysical Research Communications, 1992
- Species heterogeneity of hepatic α1-adrenoceptors: α1A-, α1B- and α1C-subtypesBiochemical and Biophysical Research Communications, 1992
- Differentiation of [3H]phencyclidine and ( + )‐[3H]SKF‐10,047 binding sites in rat cerebral cortexFEBS Letters, 1985
- The phorbol ester receptor: a phospholipid-regulated protein kinaseBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1985
- The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of ratsLife Sciences, 1982